Advances in Metastatic Breast Cancer Care: Guidance on Antibody–Drug Conjugate Therapy for the Community Multidisciplinary Team

Learn multidisciplinary strategies for integrating antibody–drug conjugates into community care for patients with metastatic breast cancer with this on-demand webcast and downloadable slides from a live workshop series.

Share

Program Content

Activities

ADCs for MBC
Advances in Metastatic Breast Cancer Care: Guidance on Antibody–Drug Conjugate Therapy for the Community Multidisciplinary Team
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: March 22, 2023

Activities

MBC ADC Community Care
Advances in Metastatic Breast Cancer Care: Guidance on Antibody–Drug Conjugate Therapy for the Community Multidisciplinary Team
Video
Congratulations: You achieved a completion on 04/09/2022

Released: August 21, 2023

Expires: August 20, 2024

Faculty

cover img faculity

Sara A. Hurvitz, MD, FACP

Professor of Medicine
Head
Division of Hematology and Oncology
Department of Medicine
UW Medicine
Senior Vice President
Clinical Research Division Fred Hutchinson Cancer Center
Seattle, Washington

cover img faculity

Rita Nanda, MD

Associate Professor of Medicine
Director, Breast Oncology
Section of Hematology/Oncology
Department of Medicine
The University of Chicago
Chicago, Illinois

cover img faculity

Sara M. Tolaney, MD, MPH

Assistant Professor of Medicine
Harvard Medical School
Associate Director
Susan F. Smith Center for Women’s Cancers
Director
Clinical Trials, Breast Oncology
Director
Breast Immunotherapy Clinical Research
Dana-Farber Cancer Institute
Boston, Massachusetts

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by educational grants from

AstraZeneca

Daiichi Sankyo, Inc.

Gilead Sciences, Inc.